Beauty Health (SKIN) Competitors $2.21 +0.14 (+6.76%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.21 0.00 (0.00%) As of 08/22/2025 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SKIN vs. PLSE, MDXG, INMD, IRMD, KMTS, EMBC, BBNX, TNDM, AXGN, and SIBNShould you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), iRadimed (IRMD), Kestra Medical Technologies (KMTS), Embecta (EMBC), Beta Bionics (BBNX), Tandem Diabetes Care (TNDM), AxoGen (AXGN), and SiBone (SIBN). These companies are all part of the "medical equipment" industry. Beauty Health vs. Its Competitors Pulse Biosciences MiMedx Group InMode iRadimed Kestra Medical Technologies Embecta Beta Bionics Tandem Diabetes Care AxoGen SiBone Beauty Health (NASDAQ:SKIN) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability. Which has more risk & volatility, SKIN or PLSE? Beauty Health has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Is SKIN or PLSE more profitable? Pulse Biosciences has a net margin of 0.00% compared to Beauty Health's net margin of -6.13%. Beauty Health's return on equity of -32.82% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Beauty Health-6.13% -32.82% -2.96% Pulse Biosciences N/A -63.19%-54.98% Do analysts recommend SKIN or PLSE? Beauty Health currently has a consensus target price of $2.63, suggesting a potential upside of 18.78%. Pulse Biosciences has a consensus target price of $22.00, suggesting a potential upside of 29.03%. Given Pulse Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Pulse Biosciences is more favorable than Beauty Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, SKIN or PLSE? Beauty Health has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeauty Health$334.30M0.84-$29.10M-$0.28-7.89Pulse Biosciences$700K1,638.75-$53.58M-$1.05-16.24 Does the media refer more to SKIN or PLSE? In the previous week, Beauty Health had 10 more articles in the media than Pulse Biosciences. MarketBeat recorded 11 mentions for Beauty Health and 1 mentions for Pulse Biosciences. Beauty Health's average media sentiment score of 1.08 beat Pulse Biosciences' score of 0.00 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in SKIN or PLSE? 93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are owned by institutional investors. 41.0% of Beauty Health shares are owned by insiders. Comparatively, 71.5% of Pulse Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryBeauty Health beats Pulse Biosciences on 9 of the 16 factors compared between the two stocks. Get Beauty Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SKIN vs. The Competition Export to ExcelMetricBeauty HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$280.28M$7.82B$5.83B$9.78BDividend YieldN/A2.69%4.40%4.05%P/E Ratio-7.8978.4731.3026.05Price / Sales0.8447.22454.60117.80Price / Cash34.9525.3638.0259.36Price / Book3.8124.799.536.60Net Income-$29.10M$243.33M$3.26B$265.65M7 Day Performance1.38%1.08%2.14%2.01%1 Month Performance9.41%-0.65%2.81%-0.33%1 Year Performance27.75%10.34%30.70%19.04% Beauty Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SKINBeauty Health1.0073 of 5 stars$2.21+6.8%$2.63+18.8%+46.4%$280.28M$334.30M-7.891,030Positive NewsPLSEPulse Biosciences3.4989 of 5 stars$15.68-3.0%$22.00+40.3%-20.8%$1.09B$700K-14.93140MDXGMiMedx Group3.2374 of 5 stars$7.19+1.1%$12.00+66.9%+11.1%$1.05B$348.88M34.24870Positive NewsINMDInMode1.9728 of 5 stars$14.31-0.3%$18.04+26.1%-4.4%$907.05M$394.82M5.79480Positive NewsIRMDiRadimed4.6447 of 5 stars$70.11-0.4%$72.00+2.7%+62.5%$895.23M$73.24M43.28110Positive NewsKMTSKestra Medical Technologies1.4769 of 5 stars$16.09+0.2%$27.33+69.9%N/A$824.15M$59.81M0.00300News CoveragePositive NewsEMBCEmbecta4.8402 of 5 stars$13.48-1.5%$19.00+40.9%+9.0%$800.66M$1.12B9.432,100Positive NewsBBNXBeta Bionics2.6034 of 5 stars$17.26+1.3%$22.56+30.7%N/A$740.73M$65.12M0.00294News CoverageInsider TradeTNDMTandem Diabetes Care4.6501 of 5 stars$10.84+0.2%$22.67+109.1%-71.9%$731.10M$940.20M-3.512,650Analyst ForecastAXGNAxoGen2.7461 of 5 stars$15.49+3.8%$26.00+67.9%+31.7%$686.97M$203.27M-154.88450Short Interest ↑SIBNSiBone4.1739 of 5 stars$15.54+0.5%$23.67+52.3%+10.0%$666.96M$167.18M-27.75350News CoverageInsider Trade Related Companies and Tools Related Companies PLSE Alternatives MDXG Alternatives INMD Alternatives IRMD Alternatives KMTS Alternatives EMBC Alternatives BBNX Alternatives TNDM Alternatives AXGN Alternatives SIBN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SKIN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Beauty Health Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Beauty Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access